These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34392980)

  • 1. Absence of coding somatic single nucleotide variants within well-known candidate genes in late-onset sporadic Alzheimer's Disease based on the analysis of multi-omics data.
    Min S; Li Z; Shieh A; Giase G; Bao R; Zhang C; Kuney L; Kopp R; Asif H; Alliey-Rodriguez N; Qin L; Craig DW; Faulkner GJ; Gershon ES; Tang B; Chen C; Liu C
    Neurobiol Aging; 2021 Dec; 108():207-209. PubMed ID: 34392980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients.
    Sala Frigerio C; Lau P; Troakes C; Deramecourt V; Gele P; Van Loo P; Voet T; De Strooper B
    Alzheimers Dement; 2015 Nov; 11(11):1265-76. PubMed ID: 25937274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Genetics of Early- and Late-Onset Alzheimer's Disease.
    Uddin MS; Hasana S; Hossain MF; Islam MS; Behl T; Perveen A; Hafeez A; Ashraf GM
    Curr Gene Ther; 2021; 21(1):43-52. PubMed ID: 33231156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene mutations in a Han Chinese Alzheimer's disease cohort.
    Ma L; Zhang J; Shi Y; Wang W; Ren Z; Xia M; Zhang Y; Yang M
    Brain Behav; 2019 Jan; 9(1):e01180. PubMed ID: 30549411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.
    Gerrish A; Russo G; Richards A; Moskvina V; Ivanov D; Harold D; Sims R; Abraham R; Hollingworth P; Chapman J; Hamshere M; Pahwa JS; Dowzell K; Williams A; Jones N; Thomas C; Stretton A; Morgan AR; Lovestone S; Powell J; Proitsi P; Lupton MK; Brayne C; Rubinsztein DC; Gill M; Lawlor B; Lynch A; Morgan K; Brown KS; Passmore PA; Craig D; McGuinness B; Todd S; Johnston JA; Holmes C; Mann D; Smith AD; Love S; Kehoe PG; Hardy J; Mead S; Fox N; Rossor M; Collinge J; Maier W; Jessen F; Kölsch H; Heun R; Schürmann B; van den Bussche H; Heuser I; Kornhuber J; Wiltfang J; Dichgans M; Frölich L; Hampel H; Hüll M; Rujescu D; Goate AM; Kauwe JS; Cruchaga C; Nowotny P; Morris JC; Mayo K; Livingston G; Bass NJ; Gurling H; McQuillin A; Gwilliam R; Deloukas P; Davies G; Harris SE; Starr JM; Deary IJ; Al-Chalabi A; Shaw CE; Tsolaki M; Singleton AB; Guerreiro R; Mühleisen TW; Nöthen MM; Moebus S; Jöckel KH; Klopp N; Wichmann HE; Carrasquillo MM; Pankratz VS; Younkin SG; Jones L; Holmans PA; O'Donovan MC; Owen MJ; Williams J
    J Alzheimers Dis; 2012; 28(2):377-87. PubMed ID: 22027014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A brief history of Alzheimer's disease gene discovery.
    Tanzi RE
    J Alzheimers Dis; 2013; 33 Suppl 1():S5-13. PubMed ID: 22986781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Study of Alzheimer's Disease in Saudi Population.
    El Bitar F; Qadi N; Al Rajeh S; Majrashi A; Abdulaziz S; Majrashi N; Al Inizi M; Taher A; Al Tassan N
    J Alzheimers Dis; 2019; 67(1):231-242. PubMed ID: 30636737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
    Cruchaga C; Haller G; Chakraverty S; Mayo K; Vallania FL; Mitra RD; Faber K; Williamson J; Bird T; Diaz-Arrastia R; Foroud TM; Boeve BF; Graff-Radford NR; St Jean P; Lawson M; Ehm MG; Mayeux R; Goate AM;
    PLoS One; 2012; 7(2):e31039. PubMed ID: 22312439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Alzheimer's disease.
    Alonso Vilatela ME; López-López M; Yescas-Gómez P
    Arch Med Res; 2012 Nov; 43(8):622-31. PubMed ID: 23142261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of Alzheimer's disease.
    Bertram L; Tanzi RE
    Prog Mol Biol Transl Sci; 2012; 107():79-100. PubMed ID: 22482448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease.
    Gao Y; Ren RJ; Zhong ZL; Dammer E; Zhao QH; Shan S; Zhou Z; Li X; Zhang YQ; Cui HL; Hu YB; Chen SD; Chen JJ; Guo QH; Wang G
    Neurobiol Aging; 2019 May; 77():154-157. PubMed ID: 30822634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetics and neuropathology of Alzheimer's disease.
    Schellenberg GD; Montine TJ
    Acta Neuropathol; 2012 Sep; 124(3):305-23. PubMed ID: 22618995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease.
    Sassi C; Guerreiro R; Gibbs R; Ding J; Lupton MK; Troakes C; Al-Sarraj S; Niblock M; Gallo JM; Adnan J; Killick R; Brown KS; Medway C; Lord J; Turton J; Bras J; ; Morgan K; Powell JF; Singleton A; Hardy J
    Neurobiol Aging; 2014 Dec; 35(12):2881.e1-2881.e6. PubMed ID: 25104557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease.
    Course MM; Gudsnuk K; Keene CD; Bird TD; Jayadev S; Valdmanis PN
    Brain; 2023 Feb; 146(2):507-518. PubMed ID: 35949106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
    PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.
    An SS; Park SA; Bagyinszky E; Bae SO; Kim YJ; Im JY; Park KW; Park KH; Kim EJ; Jeong JH; Kim JH; Han HJ; Choi SH; Kim S
    Clin Interv Aging; 2016; 11():1817-1822. PubMed ID: 28008242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.
    Guerreiro RJ; Gustafson DR; Hardy J
    Neurobiol Aging; 2012 Mar; 33(3):437-56. PubMed ID: 20594621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analyses of early-onset Alzheimer's disease using next generation sequencing.
    Giau VV; Bagyinszky E; Yang YS; Youn YC; An SSA; Kim SY
    Sci Rep; 2019 Jun; 9(1):8368. PubMed ID: 31182772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation screening in Chinese patients with familial Alzheimer's disease by whole-exome sequencing.
    Jiang B; Zhou J; Li HL; Chen YG; Cheng HR; Ye LQ; Liu DS; Chen DF; Tao QQ; Wu ZY
    Neurobiol Aging; 2019 Apr; 76():215.e15-215.e21. PubMed ID: 30598257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of homozygous and compound heterozygous missense mutations in VWA2 to Alzheimer's disease.
    Hoogmartens J; Hens E; Engelborghs S; Vandenberghe R; De Deyn PP; Cacace R; Van Broeckhoven C;
    Neurobiol Aging; 2021 Mar; 99():100.e17-100.e23. PubMed ID: 33023779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.